
Posanox100 mg
Opsonin Pharma Ltd.
Established / FDA-Approved Uses Prophylaxis of invasive Aspergillus and Candida infections in patients at high risk due to being severely immunocompromised and more.
Note: Posaconazole is a broad-spectrum antifungal reserved for confirmed or high-risk invasive fungal disease and prophylaxis in defined high-risk immunocompromised populations; it is not intended for routine or minor fungal infections.
Antifungal stewardship: Take Posaconazole exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Completing the full prescribed course is essential to prevent treatment failure and antifungal resistance.
| Population | Loading Dose (Day 1) | Maintenance Dose |
|---|---|---|
| Adults and pediatric patients ≥13 years | 300 mg twice daily | 300 mg once daily, starting Day 2; duration based on recovery from neutropenia or immunosuppression |
Swallow tablets whole with a full glass of water; do not split, crush, or chew. May be taken with or without food.
| Indication | Dose |
|---|---|
| Prophylaxis of invasive fungal infections (adults, ≥13 years) | 200 mg (5 mL) three times daily |
| Oropharyngeal candidiasis (OPC) | 100 mg twice daily on Day 1, then 100 mg once daily for 13 more days |
| OPC refractory to itraconazole/fluconazole | 400 mg (10 mL) twice daily; duration based on severity and response |
Take with a full meal or liquid nutritional supplement to maximize absorption; shake suspension well before each dose.
| Indication | Loading Dose (Day 1) | Maintenance Dose |
|---|---|---|
| Treatment of invasive aspergillosis (adults/peds ≥13 years) | 300 mg IV twice daily | 300 mg IV once daily; typical duration 6–12 weeks depending on response |
| Prophylaxis (adults and pediatrics ≥2 years, weight ≤40 kg) | 6 mg/kg (max 300 mg) twice daily | 6 mg/kg (max 300 mg) once daily |
Administer by slow intravenous infusion over approximately 90 minutes through a central venous line and an in-line filter. Do not give as an IV bolus. A peripheral line may be used only for a single dose before central line placement.
Posaconazole is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.